Myriad Genetics Inc (NASDAQ:MYGN)

25.36
Delayed Data
As of May 12
 +0.01 / +0.04%
Today’s Change
10.54
Today|||52-Week Range
33.97
+28.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line80.2M125.3M21.8M131.1M
 
 
 
 
 
Depreciation25.0M26.7M48.3M54.4M
 
 
 
 
 
Total Other Cash Flow76.4M61.6M71.4M-24.5M
 
 
 
 
 
Funds From Operations181.2M231.7M142.8M137.5M
 
 
 
 
 
Funds From/For Other Operating Expenses40.7M65.4M36.6M21.6M
 
 
 
 
 
Net Cash Flow - Operating Activities140.5M166.3M106.2M115.9M
 
 
 
 
 
 
InvestingIncrease In Investments-100.8M-164.5M-87.5M-80.9M
 
 
 
 
 
Decrease In Investments165.6M115.1M163.4M77.7M
 
 
 
 
 
Capital Expenditures-23.9M-5.0M-6.1M-8.4M
 
 
 
 
 
Fixed Asset Disposal------500.0K
 
 
Net Assets From Acquisitions ---37.0M-216.1M0.00
 
 
 
Net Cash Flow Investing40.9M-91.4M-146.3M-11.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00-1.0M0.00
 
 
Long Term Borrowings0.000.00204.0M53.0M
 
 
 
Long Term Debt Reduction0.000.00-105.0M-143.0M
 
 
 
Net Proceeds Stock Sale30.0M94.3M6.0M36.9M
 
 
 
 
 
Common Preferred Redeemed-210.7M-162.6M-31.6M0.00
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing3.4M0.000.000.00
 
 
Other Uses - Financing0.000.00600.0K42.4M
 
 
 
Net Cash Flow - Financing-177.3M-68.3M71.8M-95.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-4.8M-2.2M2.2M-800.0K
 
 
 
 
 
 
Net Change In Cash4.1M6.6M31.7M9.3M